สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์

Printed on 15 October 2026 11:29

Publication Document

Please enter search criteria
Document Type
Issuer / Underlying / Securities
Date From
To

DOD BIOTECH PUBLIC COMPANY LIMITED : DOD

The Financial Statements which need to be revised ( 3 record(s) found)
Order DateCompany NameReviewed Financial Statement Details
14/09/2026DOD BIOTECH PUBLIC COMPANY LIMITEDSEC instructs DOD to cooperate with auditor and submit rectified interim financial statements for Q1/2026 and Q2/2026
17/07/2026DOD BIOTECH PUBLIC COMPANY LIMITEDSEC allows extension of deadline for submitting DOD's rectified interim financial statements
25/06/2026DOD BIOTECH PUBLIC COMPANY LIMITEDSEC instructs DOD to cooperate with auditor and submit rectified interim financial statements
Finanacial Statements ( 68 record(s) found)
NameYearStatusTypePeriodAs OfDetails
DOD BIOTECH PUBLIC COMPANY LIMITED2026ReviewedConsolidatedQ230/06/2026
DOD BIOTECH PUBLIC COMPANY LIMITED2026ReviewedCompanyQ230/06/2026
DOD BIOTECH PUBLIC COMPANY LIMITED2026ReviewedConsolidatedQ131/03/2026
DOD BIOTECH PUBLIC COMPANY LIMITED2026ReviewedCompanyQ131/03/2026
DOD BIOTECH PUBLIC COMPANY LIMITED2025AuditedConsolidatedYear31/12/2025
DOD BIOTECH PUBLIC COMPANY LIMITED2025AuditedCompanyYear31/12/2025
DOD BIOTECH PUBLIC COMPANY LIMITED2025ReviewedConsolidatedQ330/09/2025
DOD BIOTECH PUBLIC COMPANY LIMITED2025ReviewedCompanyQ330/09/2025
DOD BIOTECH PUBLIC COMPANY LIMITED2025ReviewedConsolidatedQ230/06/2025
DOD BIOTECH PUBLIC COMPANY LIMITED2025ReviewedCompanyQ230/06/2025
Key Financial Ratio ( 0 record(s) found)
NameBusiness TypeTypePeriodYearAs OfDetails
Data not found
Management's Discussion and Analysis ( 16 record(s) found)
DateTimeHeadingLink
29/05/202608:26Management Discussion and Analysis Quarter 1 Ending 31 Mar 2026 (Revised)
26/02/202619:34Management Discussion and Analysis Yearly Ending 31 Dec 2025
23/02/202408:41Management Discussion and Analysis Yearly Ending 31 Dec 2023
19/02/202518:35Management Discussion and Analysis Yearly Ending 31 Dec 2024
15/05/202621:04Management Discussion and Analysis Quarter 1 Ending 31 Mar 2026
14/10/202619:00Management Discussion and Analysis Quarter 1 Ending 31 Mar 2026 (Revised)-Revised Auditor's Report
14/10/202618:57Management Discussion and Analysis Quarter 2 Ending 30 Jun 2026 (Revised)
14/08/202606:45Management Discussion and Analysis Quarter 2 Ending 30 Jun 2026
14/08/202606:44Management Discussion and Analysis Quarter 1 Ending 31 Mar 2026 (Revised)-Revised Auditor's Report
13/08/202517:59Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025
SEC has ordered to amend Finanacial Statements ( 0 record(s) found)
NameDescriptionDetails
Data not found

Last updated on 14 October 2026